1. Ph.Eur. European Pharmacopoeia Version 8. Vol. Version 8 (2013).
2. FDA. Guidance for Industry Orally Disintegrating Tablets,
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070578.pdf
(2008).
3. Moore, R., Watts, J., Hood, J. & Burritt, D. Intra-oral temperature variation over 24 hours. The European Journal of Orthodontics 21, 249–261,
https://doi.org/10.1093/ejo/21.3.249
(1999).
4. Mathias, P. et al. Intraoral environment conditions and their influence on marginal leakage in composite resin restorations. Acta odontologica latinoamericana: AOL 23, 105–110 (2010).
5. Yoshita, T., Uchida, S. & Namiki, N. Clinical disintegration time of orally disintegrating tablets clinically available in Japan in healthy volunteers. Biological & pharmaceutical bulletin 36, 1488–1493 (2013).